| |
@Last Software
GlycoFi
Icovia
M2S
Scribe |
M2S develops and markets FDA-approved advanced medical imaging software products and Medicare-reimbursable services for clinical diagnosis, monitoring and treatment, with a current focus on vascular disease, particularly Abdominal and Thoracic Aortic Aneurysms (AAA and TAA). With proprietary 3D-imaging technology and advanced metrics, M2S offers a complete solution to the challenges of AA disease management. |
M2S was acquired by AIG Altaris Health Partners in September 2005.
www.m2s.com |
|
